The role of non‐invasive prenatal testing (NIPT) for fetal blood group typing in Australia-Reference-Cited by-同舟云学术

The role of non‐invasive prenatal testing (NIPT) for fetal blood group typing in Australia

Published:2021-10-18 Issue: Volume: Page:
ISSN:0004-8666
Container-title:Australian and New Zealand Journal of Obstetrics and Gynaecology
language:en
Short-container-title:Aust N Z J Obstet Gynaecol

Author:

Ginige Shamila¹^ORCID,Daly James¹,Hyland Catherine¹,Powley Tanya¹,O’Brien Helen¹,Moreno Ana M.¹,Gardener Glenn²³,Flower Robert¹

Affiliation:

1. Australian Red Cross Lifeblood Brisbane QueenslandAustralia

2. Mater Centre for Maternal Fetal Medicine Brisbane QueenslandAustralia

3. Mater Research Institute at the University of Queensland Brisbane Queensland Australia

Publisher

Wiley

Subject

Obstetrics and Gynecology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajo.13446

Reference19 articles.

1. Presence of fetal DNA in maternal plasma and serum;Lo YM;Lancet,1997

2. National Blood Authority Australia.Guidelines for the prophylactic use of RhD immunoglobulin in pregnancy care.2021.

3. Haemolytic disease of the fetus and newborn;Haas M;Vox Sang,2015

4. International Society of Blood Transfusion (ISBT) [Online]. Available:http://www.isbtweb.org/working‐parties/red‐cell‐immunogenetics‐and‐blood‐group‐terminology. [Accessed Jan 2021].

5. Royal College of Obstetricians and Gynaecologists.The management of women with red cell antibodies during pregnancy.2014.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Equity in blood transfusion precision services;International Journal for Equity in Health;2024-04-18

2. Antenatal RHD screening to guide antenatal anti-D immunoprophylaxis in non-immunized D– pregnant women;Immunohematology;2024-04-01